Funds awarded for MS drug clinical trial
Funds awarded for MS drug clinical trial
Trophos has been awarded a €1 million (approximately $1.29 million) grant from the French Agence Nationale de la Recherche (ANR) to support Translate-MS-Repair, a two-year collaborative R&D project that will evaluate the firm’s lead olesoxime candidate in a Phase Ib/IIa multiple sclerosis (MS) study.
The grant is the second awarded by the ANR and follows on from its support of the MS-Repair project, also led by Trophos, which evaluated olesoxime in a range of in vitro and in vivo MS models and demonstrated that the molecule is neuroprotective but can promote oligodentrocyte progenitor cells' maturation into myelinating oligodendrocytes.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2479
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 10229 Views
-
Last post by NHE
-
- 0 Replies
- 954 Views
-
Last post by frodo
-
- 0 Replies
- 1360 Views
-
Last post by DIM
-
- 0 Replies
- 2028 Views
-
Last post by NHE
-
- 0 Replies
- 10610 Views
-
Last post by NHE
-
- 0 Replies
- 2169 Views
-
Last post by NHE
-
- 0 Replies
- 1296 Views
-
Last post by NHE
-
- 1 Replies
- 2700 Views
-
Last post by Tif
-
- 2 Replies
- 744 Views
-
Last post by DIM